c

Nice | Ticagrelor for the treatment of acute coronary syndrome ACS

4th November 2011 by Louise Hudman

Ticagrelor is a PO drug which inhibits platelet aggregation. In combination with aspirin it is more effective than clopidogrel + aspirin at reducing the endpoint of MI or death from vascular events.

It will be started by secondary care and continued by cardiologists, so we shouldn’t really have to initiate it.

It will be started in patients who’ve had a STEMI where primary percutaneous coronary intervention (PCI) is considered and also in patients with a NSTEMI who have certain other risk factors.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"Joining NASGP's Locum Chambers in Essex after CCT has been a fantastic decision for me. The Chambers structure provides support with my locum work as well as a peer support network with regular meetings.

The Chambers support also extends to support with complaints when these occur. This is an amazing benefit that helps to minimise the professional isolation that can come with being a locum.

The Instant Book feature within LocumDeck makes arranging sessions easy. Whilst getting things set up initially does take a bit of work, this eventually pays off and the return on this initial time investment is impressive. New features are always being added based on feedback from members. "

Dr Shanil Shivji, GP, Essex

See the full list of features within our NASGP membership plans

Membership